Poster sessions at WCLC 2026 detail how surgery, nursing, and pathology can contribute to the multidisciplinary care of patients with lung cancer.
|Videos|June 6, 2017
Maintenance Pembrolizumab Did Not Improve PFS in Small-Cell Lung Cancer
Author(s)Shirish M. Gadgeel, MD
This video examines a phase II trial that studied maintenance pembrolizumab in extensive-stage small-cell lung cancer.
Advertisement
In this video, Shirish M. Gadgeel, MD, of the University of Michigan, discusses a phase II trial that studied pembrolizumab in the maintenance setting for the treatment of extensive-stage small-cell lung cancer patients.
Gadgeel presented results of the study (
Advertisement
Related to this article
Medical oncologists, clinical pharmacists, and oncologic nurse practitioners share the presentation topics to look out for at WCLC 2026.
Advertisement
Advertisement
Trending on CancerNetwork
1
Lutetium Lu 177 Dotatate Biosimilar Earns Final FDA Approval in GEP-NETs
2
PANXEON Liquid Biopsy Demonstrates Potential for Detecting Early Pancreatic Cancer
3
Rusfertide Earns Category 1 NCCN Recommendation in Polycythemia Vera
4
AdenoVerse Platform Receives FDA Designation for HPV-Associated Cancers
5